1 "VEGF couples hypertrophic cartilate remodeling, ossification and angiogenesis during endochondral ossification" 5 : 623-628, 1999
2 "Tumor necrosis factor-alpha upregulates angiopoietin-2 in human umbilical vein endothelial cells" 269 : 361-365, 2000
3 "Tie2 ligand angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone" 28 : 65-71, 2001
4 "Tie-2 receptor ligands, angiopoietin-1 and angiopoietin-2 modulate VEGF-induced postnasal neovasculaisation" 83 : 233-240, 1998
5 "The role of alkaline phosphatase in osteogenesis" 93 : 415-422, 1951
6 "The matrix-degrading metalloproteinases" 14 : 455-463, 1992
7 "Role of nitric oxide in the regulation of osteoblast metabolism" 100 : 670-673, 1997
8 "Requisite role of angiopoietin-1, a ligand for Tie2 receptor, during embryonic angiogenesis" 87 : 1171-1180, 1996
9 "Recent data on the role for angiogenesis in rheumatoid arthritis" 70 : 321-326, 2003
10 "Preclinical safety evaluation of rhuMabVEGF, an angiangiogenic humanized monoclonal antibody" 27 : 78-86, 1999
1 "VEGF couples hypertrophic cartilate remodeling, ossification and angiogenesis during endochondral ossification" 5 : 623-628, 1999
2 "Tumor necrosis factor-alpha upregulates angiopoietin-2 in human umbilical vein endothelial cells" 269 : 361-365, 2000
3 "Tie2 ligand angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone" 28 : 65-71, 2001
4 "Tie-2 receptor ligands, angiopoietin-1 and angiopoietin-2 modulate VEGF-induced postnasal neovasculaisation" 83 : 233-240, 1998
5 "The role of alkaline phosphatase in osteogenesis" 93 : 415-422, 1951
6 "The matrix-degrading metalloproteinases" 14 : 455-463, 1992
7 "Role of nitric oxide in the regulation of osteoblast metabolism" 100 : 670-673, 1997
8 "Requisite role of angiopoietin-1, a ligand for Tie2 receptor, during embryonic angiogenesis" 87 : 1171-1180, 1996
9 "Recent data on the role for angiogenesis in rheumatoid arthritis" 70 : 321-326, 2003
10 "Preclinical safety evaluation of rhuMabVEGF, an angiangiogenic humanized monoclonal antibody" 27 : 78-86, 1999
11 "Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures" 122 : 1373-1382, 1988
12 "Matrix metalloproteinases and metastasis" 43 : 42-51, 1999
13 "Isolation of agniopoietin-1,a ligand for the TIE1 receptor,by secretion-trap expression cloning" 87 : 1161-1169, 1996
14 "Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein" 21 : 1146-1151, 2001
15 "Induction of calcitonin receptors by 1,25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells" 123 : 1504-1510, 1988
16 "Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage" 194 : 519-524, 1999
17 "Growth factors and the regulation of bone remodeling" 81 : 277-281, 1988
18 "Expression of angiopoietin-1, angiopoietin-2, and the tie2 receptor tyrosine kinase during mouse kidney maturation" 10 : 1722-1736, 1999
19 "Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors" 79 : 213-223, 1999
20 "Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzyme required for extracellular matrix digestion" 75 : 181-189, 1994
21 "Cells of bone" 855-886,
22 "Cartilage to bone- angiogenesis leads the way" 5 : 617-618, 1999
23 "Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization" 83 : 1637-1645, 2003
24 "Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis" 277 : 55-60, 1997
25 "Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2" 100 : 8904-8909, 2003
26 "Alkaline phosphatase and bone calcium parameters" 7 : 95-99, 1986